Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019

Detalhes bibliográficos
Autor(a) principal: João, Eva D.
Data de Publicação: 2020
Outros Autores: Munlela, Benilde, Chissaque, Assucênio, Chilaúle, Jorfélia, Langa, Jerónimo, Augusto, Orvalho, Boene, Simone S., Anapakala, Elda, Sambo, Júlia, Guimarães, Esperança, Bero, Diocreciano, Cassocera, Marta, Cossa-Moiane, Idalécia, Mwenda, Jason M., Maurício, Isabel, O’neill, Hester G., de Deus, Nilsa
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/116616
Resumo: Group A rotavirus (RVA) remains the most important etiological agent associated with severe acute diarrhea in children. Rotarix® monovalent vaccine was introduced into Mozambique’s Expanded Program on Immunization in September 2015. In the present study, we report the diversity and prevalence of rotavirus genotypes, pre-(2012–2015) and post-vaccine (2016–2019) introduction in Mozambique, among diarrheic children less than five years of age. Genotyping data were analyzed for five sentinel sites for the periods indicated. The primary sentinel site, Mavalane General Hospital (HGM), was analyzed for the period 2012–2019, and for all five sites (country-wide analyses), 2015–2019. During the pre-vaccine period, G9P[8] was the most predominant genotype for both HGM (28.5%) and the country-wide analysis (46.0%). However, in the post-vaccine period, G9P[8] was significantly reduced. Instead, G3P[8] was the most common genotype at HGM, while G1P[8] predominated country-wide. Genotypes G9P[4] and G9P[6] were detected for the first time, and the emergence of G3P[8] and G3P[4] genotypes were observed during the post-vaccine period. The distribution and prevalence of rotavirus genotypes were distinct in pre-and post-vaccination periods, while uncommon genotypes were also detected in the post-vaccine period. These observations support the need for continued country-wide surveillance to monitor changes in strain diversity, due to possible vaccine pressure, and consequently, the effect on vaccine effectiveness.
id RCAP_5f52cdbcd6fd1611d3e9b33de306d52b
oai_identifier_str oai:run.unl.pt:10362/116616
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019emergence of genotypes G3P[4] and G3P[8]G3 genotypeMozambique vaccine surveillanceRotarixRotavirus type AImmunology and AllergyMolecular BiologyImmunology and Microbiology(all)Microbiology (medical)Infectious DiseasesSDG 3 - Good Health and Well-beingGroup A rotavirus (RVA) remains the most important etiological agent associated with severe acute diarrhea in children. Rotarix® monovalent vaccine was introduced into Mozambique’s Expanded Program on Immunization in September 2015. In the present study, we report the diversity and prevalence of rotavirus genotypes, pre-(2012–2015) and post-vaccine (2016–2019) introduction in Mozambique, among diarrheic children less than five years of age. Genotyping data were analyzed for five sentinel sites for the periods indicated. The primary sentinel site, Mavalane General Hospital (HGM), was analyzed for the period 2012–2019, and for all five sites (country-wide analyses), 2015–2019. During the pre-vaccine period, G9P[8] was the most predominant genotype for both HGM (28.5%) and the country-wide analysis (46.0%). However, in the post-vaccine period, G9P[8] was significantly reduced. Instead, G3P[8] was the most common genotype at HGM, while G1P[8] predominated country-wide. Genotypes G9P[4] and G9P[6] were detected for the first time, and the emergence of G3P[8] and G3P[4] genotypes were observed during the post-vaccine period. The distribution and prevalence of rotavirus genotypes were distinct in pre-and post-vaccination periods, while uncommon genotypes were also detected in the post-vaccine period. These observations support the need for continued country-wide surveillance to monitor changes in strain diversity, due to possible vaccine pressure, and consequently, the effect on vaccine effectiveness.Instituto de Higiene e Medicina Tropical (IHMT)Global Health and Tropical Medicine (GHTM)Vector borne diseases and pathogens (VBD)RUNJoão, Eva D.Munlela, BenildeChissaque, AssucênioChilaúle, JorféliaLanga, JerónimoAugusto, OrvalhoBoene, Simone S.Anapakala, EldaSambo, JúliaGuimarães, EsperançaBero, DiocrecianoCassocera, MartaCossa-Moiane, IdaléciaMwenda, Jason M.Maurício, IsabelO’neill, Hester G.de Deus, Nilsa2021-05-01T22:51:42Z2020-08-192020-08-19T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article16application/pdfhttp://hdl.handle.net/10362/116616eng2076-0817PURE: 19930925https://doi.org/10.3390/pathogens9090671info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:59:16Zoai:run.unl.pt:10362/116616Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:43:10.202713Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019
emergence of genotypes G3P[4] and G3P[8]
title Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019
spellingShingle Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019
João, Eva D.
G3 genotype
Mozambique vaccine surveillance
Rotarix
Rotavirus type A
Immunology and Allergy
Molecular Biology
Immunology and Microbiology(all)
Microbiology (medical)
Infectious Diseases
SDG 3 - Good Health and Well-being
title_short Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019
title_full Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019
title_fullStr Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019
title_full_unstemmed Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019
title_sort Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019
author João, Eva D.
author_facet João, Eva D.
Munlela, Benilde
Chissaque, Assucênio
Chilaúle, Jorfélia
Langa, Jerónimo
Augusto, Orvalho
Boene, Simone S.
Anapakala, Elda
Sambo, Júlia
Guimarães, Esperança
Bero, Diocreciano
Cassocera, Marta
Cossa-Moiane, Idalécia
Mwenda, Jason M.
Maurício, Isabel
O’neill, Hester G.
de Deus, Nilsa
author_role author
author2 Munlela, Benilde
Chissaque, Assucênio
Chilaúle, Jorfélia
Langa, Jerónimo
Augusto, Orvalho
Boene, Simone S.
Anapakala, Elda
Sambo, Júlia
Guimarães, Esperança
Bero, Diocreciano
Cassocera, Marta
Cossa-Moiane, Idalécia
Mwenda, Jason M.
Maurício, Isabel
O’neill, Hester G.
de Deus, Nilsa
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Instituto de Higiene e Medicina Tropical (IHMT)
Global Health and Tropical Medicine (GHTM)
Vector borne diseases and pathogens (VBD)
RUN
dc.contributor.author.fl_str_mv João, Eva D.
Munlela, Benilde
Chissaque, Assucênio
Chilaúle, Jorfélia
Langa, Jerónimo
Augusto, Orvalho
Boene, Simone S.
Anapakala, Elda
Sambo, Júlia
Guimarães, Esperança
Bero, Diocreciano
Cassocera, Marta
Cossa-Moiane, Idalécia
Mwenda, Jason M.
Maurício, Isabel
O’neill, Hester G.
de Deus, Nilsa
dc.subject.por.fl_str_mv G3 genotype
Mozambique vaccine surveillance
Rotarix
Rotavirus type A
Immunology and Allergy
Molecular Biology
Immunology and Microbiology(all)
Microbiology (medical)
Infectious Diseases
SDG 3 - Good Health and Well-being
topic G3 genotype
Mozambique vaccine surveillance
Rotarix
Rotavirus type A
Immunology and Allergy
Molecular Biology
Immunology and Microbiology(all)
Microbiology (medical)
Infectious Diseases
SDG 3 - Good Health and Well-being
description Group A rotavirus (RVA) remains the most important etiological agent associated with severe acute diarrhea in children. Rotarix® monovalent vaccine was introduced into Mozambique’s Expanded Program on Immunization in September 2015. In the present study, we report the diversity and prevalence of rotavirus genotypes, pre-(2012–2015) and post-vaccine (2016–2019) introduction in Mozambique, among diarrheic children less than five years of age. Genotyping data were analyzed for five sentinel sites for the periods indicated. The primary sentinel site, Mavalane General Hospital (HGM), was analyzed for the period 2012–2019, and for all five sites (country-wide analyses), 2015–2019. During the pre-vaccine period, G9P[8] was the most predominant genotype for both HGM (28.5%) and the country-wide analysis (46.0%). However, in the post-vaccine period, G9P[8] was significantly reduced. Instead, G3P[8] was the most common genotype at HGM, while G1P[8] predominated country-wide. Genotypes G9P[4] and G9P[6] were detected for the first time, and the emergence of G3P[8] and G3P[4] genotypes were observed during the post-vaccine period. The distribution and prevalence of rotavirus genotypes were distinct in pre-and post-vaccination periods, while uncommon genotypes were also detected in the post-vaccine period. These observations support the need for continued country-wide surveillance to monitor changes in strain diversity, due to possible vaccine pressure, and consequently, the effect on vaccine effectiveness.
publishDate 2020
dc.date.none.fl_str_mv 2020-08-19
2020-08-19T00:00:00Z
2021-05-01T22:51:42Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/116616
url http://hdl.handle.net/10362/116616
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2076-0817
PURE: 19930925
https://doi.org/10.3390/pathogens9090671
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 16
application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138041900564480